Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Asthma I: Introduction01:28

Asthma I: Introduction

112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Group 2 innate lymphoid cells: Where are we 15 years out?

The Journal of allergy and clinical immunology·2026
Same author

Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders.

ImmunoTargets and therapy·2026
Same author

Sinus mast cell accumulation and persistence suggest a unique endotype in toxin exposure-associated chronic rhinosinusitis.

The Journal of clinical investigation·2026
Same author

Time-restricted eating improves quality of life, heart rate, and mitochondrial function in patients with postural orthostatic tachycardia syndrome. An open-label pilot study.

Scientific reports·2025
Same author

Activation of IL-17+ ILC subsets in IL-18R-deficient mice during fungal allergen exposure.

bioRxiv : the preprint server for biology·2025
Same author

Fine-Tuning Group 2 Innate Lymphoid Cells: CD48 Pumps Up the Volume.

American journal of respiratory cell and molecular biology·2025
Same journal

Chasing down the triple-negative myeloproliferative neoplasms: Implications for molecular diagnostics.

JAK-STAT·2017
Same journal

Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

JAK-STAT·2016
Same journal

IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor.

JAK-STAT·2016
Same journal

STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

JAK-STAT·2016
Same journal

LIF signal in mouse embryonic stem cells.

JAK-STAT·2016
Same journal

Mitochondrial STAT3 and reactive oxygen species: A fulcrum of adipogenesis?

JAK-STAT·2016
See all related articles

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

915

STAT6 and lung inflammation.

Hannah H Walford1, Taylor A Doherty2

  • 1Department of Medicine; University of California, San Diego; La Jolla, CA USA ; Department of Pediatrics; University of California, San Diego; La Jolla, CA USA.

JAK-STAT
|January 14, 2014
PubMed
Summary
This summary is machine-generated.

Signal transducer and activator of transcription 6 (STAT6) plays a key role in lung inflammation, including asthma and anti-viral responses. Understanding STAT6 mechanisms is crucial for developing new lung disease therapies targeting this pathway.

Keywords:
IL-13IL-4STAT6Th2asthma

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

4.7K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

915
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

4.7K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Area of Science:

  • Immunology
  • Pulmonology
  • Molecular Biology

Background:

  • Lung inflammation involves complex interactions between immune and structural cells.
  • Th2-type immunity, such as asthma, is a major cause of lung inflammation.
  • Signal transducer and activator of transcription 6 (STAT6) is a critical regulator in inflammatory pathways.

Purpose of the Study:

  • To review the role of STAT6 in various lung diseases.
  • To elucidate the mechanisms by which STAT6 influences lung cell function.
  • To highlight the therapeutic potential of targeting the IL-4/IL-13/STAT6 pathway.

Main Methods:

  • Review of existing literature on STAT6 function in lung inflammation.
  • Analysis of animal models demonstrating STAT6's role in lung pathology.
  • Discussion of clinical relevance and therapeutic targeting strategies.

Main Results:

  • STAT6 regulates key features of lung inflammation, including airway eosinophilia, mucus production, and Th2 cell differentiation.
  • Elevated IL-4 and IL-13 cytokines, upstream of STAT6, are implicated in human asthma.
  • Emerging evidence suggests STAT6 involvement in anti-viral responses and pulmonary fibrosis.

Conclusions:

  • STAT6 is a central mediator in diverse lung inflammatory conditions.
  • Targeting the IL-4/IL-13/STAT6 pathway holds promise for treating lung diseases like asthma.
  • Further research into STAT6 mechanisms can uncover novel therapeutic strategies for pulmonary fibrosis and viral infections.